Adherence  	Adherence  	 JJ	O
to  	to  	 TO	O
disease-modifying  	disease-modifying  	 JJ	O
therapies  	therapies  	 NNS	O
and  	and  	 CC	O
attitudes  	attitudes  	 NNS	O
regarding  	regarding  	 VBG	B-NP
disease  	disease  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
multiple  	multiple  	 JJ	O
sclerosis  	sclerosis  	 NN	O
Although  	Although  	 IN	O
currently  	currently  	 RB	O
there  	there  	 EX	O
is  	is  	 VBZ	O
no  	no  	 DT	O
cure  	cure  	 NN	O
for  	for  	 IN	O
MS  	MS  	 NNP	B-NP
the  	the  	 DT	O
course  	course  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
disease  	disease  	 NN	O
can  	can  	 MD	O
be  	be  	 VB	O
influenced  	influenced  	 VBN	O
by  	by  	 IN	O
disease  	disease  	 NN	B-NP
modifying  	modifying  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
( 	( 	 -LRB-	O
DMT 	DMT 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
therapy  	therapy  	 NN	O
to  	to  	 TO	O
be  	be  	 VB	O
sufficiently  	sufficiently  	 RB	O
efficient 	efficient 	 JJ	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
crucial  	crucial  	 JJ	O
that  	that  	 IN	O
patients  	patients  	 NNS	O
take  	take  	 VBP	O
their  	their  	 PRP$	O
medication  	medication  	 NN	O
regularly  	regularly  	 RB	O
as  	as  	 RB	O
prescribed 	prescribed 	 VBN	O
.  	.  	 .	O
Adherence  	Adherence  	 NNP	O
describes  	describes  	 VBZ	O
the  	the  	 DT	O
extent  	extent  	 NN	O
to  	to  	 TO	O
which  	which  	 WDT	O
a  	a  	 DT	O
patient  	patient  	 JJ	O
acts  	acts  	 NNS	O
in  	in  	 IN	O
accordance  	accordance  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
prescribed  	prescribed  	 JJ	O
timing 	timing 	 NN	O
,  	,  	 ,	O
dosing 	dosing 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
frequency  	frequency  	 NN	O
of  	of  	 IN	O
medication  	medication  	 NN	B-NP
administration 	administration 	 NN	I-NP
.  	.  	 .	O
To  	To  	 TO	O
date 	date 	 NN	O
,  	,  	 ,	O
there  	there  	 EX	O
are  	are  	 VBP	O
no  	no  	 RB	O
known  	known  	 VBN	O
data  	data  	 NNS	O
about  	about  	 IN	O
adherence  	adherence  	 JJ	B-NP
rates  	rates  	 NNS	I-NP
among  	among  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
MS  	MS  	 NNP	B-NP
in  	in  	 IN	O
Slovenia 	Slovenia 	 NNP	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
wanted  	wanted  	 VBD	O
to  	to  	 TO	O
assess  	assess  	 VB	O
adherence  	adherence  	 VBN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
MS 	MS 	 NNP	B-NP
,  	,  	 ,	O
who  	who  	 WP	O
are  	are  	 VBP	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
first  	first  	 JJ	O
line  	line  	 NN	B-NP
DMTs  	DMTs  	 NN	I-NP
and  	and  	 CC	O
discover  	discover  	 JJ	O
reasons  	reasons  	 NNS	O
for  	for  	 IN	O
non-adherence 	non-adherence 	 JJ	B-NP
.  	.  	 .	O
A  	A  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
451  	451  	 CD	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
invited  	invited  	 VBN	O
to  	to  	 TO	O
participate 	participate 	 VB	O
.  	.  	 .	O
They  	They  	 PRP	O
received  	received  	 VBD	O
two  	two  	 CD	O
questionnaires  	questionnaires  	 NN	O
via  	via  	 IN	O
post  	post  	 NN	O
mail 	mail 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
adherence  	adherence  	 JJ	B-NP
rate  	rate  	 NN	I-NP
and  	and  	 CC	O
putative  	putative  	 JJ	B-NP
reasons  	reasons  	 NNS	I-NP
for  	for  	 IN	I-NP
non-adherence  	non-adherence  	 NNP	I-NP
were  	were  	 VBD	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
standardized  	standardized  	 JJ	O
self-report  	self-report  	 JJ	B-NP
Multiple  	Multiple  	 NNP	I-NP
Sclerosis  	Sclerosis  	 NNP	I-NP
Treatment  	Treatment  	 NNP	I-NP
Experience  	Experience  	 NNP	I-NP
Questionnaire  	Questionnaire  	 NNP	I-NP
( 	( 	 -LRB-	O
MSTEQ 	MSTEQ 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Patients 	Patients 	 NNS	O
'  	'  	 POS	O
attitudes  	attitudes  	 NNS	O
regarding  	regarding  	 VBG	B-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
therapy  	therapy  	 NN	O
and  	and  	 CC	O
relationship  	relationship  	 NN	B-NP
with  	with  	 IN	O
their  	their  	 PRP$	O
physician  	physician  	 NN	O
were  	were  	 VBD	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
another  	another  	 DT	O
questionnaire 	questionnaire 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
results  	results  	 NNS	O
included  	included  	 VBD	O
299  	299  	 CD	O
patients 	patients 	 NNS	O
.  	.  	 .	O
Among  	Among  	 IN	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
18.5 	18.5 	 CD	O
%  	%  	 NN	O
missed  	missed  	 VBN	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
medication  	medication  	 NN	B-NP
dose  	dose  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
past  	past  	 JJ	O
28  	28  	 CD	O
days 	days 	 NNS	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
taking  	taking  	 VBG	O
Avonex  	Avonex  	 NNP	B-NP
were  	were  	 VBD	O
significantly  	significantly  	 RB	O
more  	more  	 JJR	O
adherent  	adherent  	 NNS	B-NP
then  	then  	 RB	O
patients  	patients  	 NNS	O
on  	on  	 IN	O
other  	other  	 JJ	O
DMTs  	DMTs  	 NN	B-NP
( 	( 	 -LRB-	O
p=0.005 	p=0.005 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
study  	study  	 NN	O
showed  	showed  	 VBD	O
a  	a  	 DT	O
higher  	higher  	 RBR	O
then  	then  	 RB	O
expected  	expected  	 VBN	B-NP
adherence  	adherence  	 VBN	I-NP
among  	among  	 IN	O
Slovenian  	Slovenian  	 JJ	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
MS  	MS  	 NNP	B-NP
( 	( 	 -LRB-	O
81.5 	81.5 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
research  	research  	 NN	O
did  	did  	 VBD	O
not  	not  	 RB	O
confirm  	confirm  	 VB	O
the  	the  	 DT	O
influence  	influence  	 NN	O
of  	of  	 IN	O
side  	side  	 NN	B-NP
effects  	effects  	 NNS	I-NP
or  	or  	 CC	O
patients 	patients 	 NNS	O
'  	'  	 POS	O
attitudes  	attitudes  	 NNS	O
regarding  	regarding  	 VBG	B-NP
illness  	illness  	 NN	I-NP
and  	and  	 CC	O
therapy  	therapy  	 NN	O
on  	on  	 IN	O
adherence 	adherence 	 NN	O
.  	.  	 .	O
However  	However  	 RB	O
we  	we  	 PRP	O
found  	found  	 VBD	O
unexpectedly  	unexpectedly  	 RB	O
high  	high  	 JJ	O
percentage  	percentage  	 NN	O
( 	( 	 -LRB-	O
71.8 	71.8 	 NNP	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
patients  	patients  	 NNS	B-NP
belief  	belief  	 NN	I-NP
that  	that  	 IN	O
psychological  	psychological  	 JJ	B-NP
factors  	factors  	 NNS	I-NP
are  	are  	 VBP	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
MS  	MS  	 NNP	B-NP
aetiology 	aetiology 	 NN	I-NP
.  	.  	 .	O
